Advent set to buy Suven Pharma for Rs 6300 cr

Advent International is expected to sign a binding agreement to buy Suven Pharmaceuticals, a Hyderabad-based listed contract research and manufacturing services (CRAMS) company, as early as Monday morning, people familiar with the matter told...

Top three trends in Veterinary pharmaceuticals market

In this article lets look into the key trends in Veterinary drugs market.

Top Three Technologies Revolutionizing the Adult Vaccine Market

The rise in number of government initiatives with an aim to avert certain diseases and epidemics are anticipated to fuel the adult vaccines market growth. Right from the invention of vaccines they have revolutionized the healthcare industry.

Alembic Pharma receives USFDA nod for Pregabalin capsules

Alembic Pharmaceuticals Limited announced that it has received PAS (Prior Approval Supplement) approval from the US Food Drug Administration (USFDA) for its supplemental Abbreviated New Drug Application (sANDA) Pregabalin capsules, 25 mg, 50 mg,...

BeatO appoints Dr Navneet Agrawal as chief clinical officer

BeatO, a comprehensive digital diabetes care platform for controlling and reversing diabetes, has announced the appointment of Dr. Navneet Agrawal as its chief clinical officer. Dr. Navneet Agrawal will head BeatO’s proprietary Diabetes Care...

C-CAMP & Netherlands Embassy in India launch WAH! Accelerator to fulfil the One Health Vision to address AMR

Centre for Cellular and Molecular Platforms (C-CAMP) an initiative supported by Department of Biotechnology is delighted to announce a next-generation Indo-Dutch bilateral collaboration to address the challenge posed by antimicrobial resistance...

All India Institute of Ayurveda organises National Workshop on Ayurveda Nephrology

The All India Institute of Ayurveda has organised a national workshop today on Ayurveda Nephorology - Vrikka Sambhashna...

Guerison expands into the Indian ophthalmology market

Guerison, a global pharmaceutical company having a surgical business in Dubai, is setting its footprints in India’s ophthalmology market with the highest ethics, top development, and utmost safety standards...

EnginZyme raises 21 million in Series B to amplify the commercialisation of its cell-free biomanufacturing technology

EnginZyme, a green tech company developing biomanufacturing processes for the sustainable manufacturing of everyday products, announced that it had raised €21 million in a Series B financing round...

Global Pharmaceutical Company Dr Reddy's completes phase 1 study of DRL_TC, proposed biosimilar of tocilizumab

Dr Reddy’s Laboratories Ltd, a global pharmaceutical company, announced that its tocilizumab biosimilar candidate, DRL_TC, successfully met its primary and secondary endpoints in a phase 1 study. This phase 1 study used a subcutaneous formulation...

© 2025 India Pharma Outlook. All Rights Reserved.